vs
Side-by-side financial comparison of Mama's Creations, Inc. (MAMA) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $47.3M, roughly 2.0× Mama's Creations, Inc.). Vericel Corp runs the higher net margin — 25.0% vs 1.1%, a 23.9% gap on every dollar of revenue. On growth, Mama's Creations, Inc. posted the faster year-over-year revenue change (50.0% vs 23.3%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $3.7M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 33.0%).
Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
MAMA vs VCEL — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.3M | $92.9M |
| Net Profit | $540.0K | $23.2M |
| Gross Margin | 23.6% | 78.7% |
| Operating Margin | 1.7% | 24.1% |
| Net Margin | 1.1% | 25.0% |
| Revenue YoY | 50.0% | 23.3% |
| Net Profit YoY | 31.7% | 17.3% |
| EPS (diluted) | $0.01 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.3M | $92.9M | ||
| Q3 25 | $35.2M | $67.5M | ||
| Q2 25 | $35.3M | $63.2M | ||
| Q1 25 | $33.6M | $52.6M | ||
| Q4 24 | $31.5M | $75.4M | ||
| Q3 24 | $28.4M | $57.9M | ||
| Q2 24 | $29.8M | $52.7M | ||
| Q1 24 | $26.7M | $51.3M |
| Q4 25 | $540.0K | $23.2M | ||
| Q3 25 | $1.3M | $5.1M | ||
| Q2 25 | $1.2M | $-553.0K | ||
| Q1 25 | $1.6M | $-11.2M | ||
| Q4 24 | $410.0K | $19.8M | ||
| Q3 24 | $1.1M | $-901.0K | ||
| Q2 24 | $553.0K | $-4.7M | ||
| Q1 24 | $1.4M | $-3.9M |
| Q4 25 | 23.6% | 78.7% | ||
| Q3 25 | 24.9% | 73.5% | ||
| Q2 25 | 26.1% | 73.7% | ||
| Q1 25 | 27.0% | 69.0% | ||
| Q4 24 | 22.6% | 77.6% | ||
| Q3 24 | 24.2% | 71.9% | ||
| Q2 24 | 25.0% | 69.5% | ||
| Q1 24 | 29.3% | 68.9% |
| Q4 25 | 1.7% | 24.1% | ||
| Q3 25 | 4.8% | 5.1% | ||
| Q2 25 | 4.5% | -3.2% | ||
| Q1 25 | 5.7% | -24.3% | ||
| Q4 24 | 1.8% | 24.5% | ||
| Q3 24 | 5.7% | -4.3% | ||
| Q2 24 | 2.6% | -11.5% | ||
| Q1 24 | 7.4% | -10.7% |
| Q4 25 | 1.1% | 25.0% | ||
| Q3 25 | 3.6% | 7.5% | ||
| Q2 25 | 3.5% | -0.9% | ||
| Q1 25 | 4.8% | -21.4% | ||
| Q4 24 | 1.3% | 26.3% | ||
| Q3 24 | 4.0% | -1.6% | ||
| Q2 24 | 1.9% | -8.9% | ||
| Q1 24 | 5.3% | -7.5% |
| Q4 25 | $0.01 | $0.46 | ||
| Q3 25 | $0.03 | $0.10 | ||
| Q2 25 | $0.03 | $-0.01 | ||
| Q1 25 | $0.04 | $-0.23 | ||
| Q4 24 | $0.01 | $0.40 | ||
| Q3 24 | $0.03 | $-0.02 | ||
| Q2 24 | $0.01 | $-0.10 | ||
| Q1 24 | $0.03 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.1M | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $49.6M | $354.6M |
| Total Assets | $84.0M | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.1M | $137.5M | ||
| Q3 25 | $9.4M | $135.4M | ||
| Q2 25 | $12.0M | $116.9M | ||
| Q1 25 | $7.2M | $112.9M | ||
| Q4 24 | $9.3M | $116.2M | ||
| Q3 24 | $7.4M | $101.7M | ||
| Q2 24 | $13.0M | $102.5M | ||
| Q1 24 | $11.0M | $110.6M |
| Q4 25 | $49.6M | $354.6M | ||
| Q3 25 | $29.6M | $321.9M | ||
| Q2 25 | $26.4M | $306.8M | ||
| Q1 25 | $24.9M | $295.5M | ||
| Q4 24 | $23.0M | $292.0M | ||
| Q3 24 | $22.3M | $257.5M | ||
| Q2 24 | $20.3M | $243.0M | ||
| Q1 24 | $19.6M | $233.9M |
| Q4 25 | $84.0M | $488.0M | ||
| Q3 25 | $51.2M | $453.3M | ||
| Q2 25 | $52.7M | $435.6M | ||
| Q1 25 | $47.1M | $424.6M | ||
| Q4 24 | $47.9M | $432.7M | ||
| Q3 24 | $43.0M | $390.4M | ||
| Q2 24 | $47.2M | $376.8M | ||
| Q1 24 | $45.1M | $356.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.9M | $15.0M |
| Free Cash FlowOCF − Capex | $3.7M | $12.8M |
| FCF MarginFCF / Revenue | 7.8% | 13.8% |
| Capex IntensityCapex / Revenue | 0.4% | 2.4% |
| Cash ConversionOCF / Net Profit | 7.16× | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $6.0M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.9M | $15.0M | ||
| Q3 25 | $-1.7M | $22.1M | ||
| Q2 25 | $6.0M | $8.2M | ||
| Q1 25 | $-857.0K | $6.6M | ||
| Q4 24 | $4.8M | $22.2M | ||
| Q3 24 | $-2.4M | $10.2M | ||
| Q2 24 | $3.6M | $18.5M | ||
| Q1 24 | $6.7M | $7.2M |
| Q4 25 | $3.7M | $12.8M | ||
| Q3 25 | $-2.2M | $19.5M | ||
| Q2 25 | $5.5M | $81.0K | ||
| Q1 25 | $-930.0K | $-7.6M | ||
| Q4 24 | $2.5M | $8.5M | ||
| Q3 24 | $-4.0M | $-9.2M | ||
| Q2 24 | $2.5M | $1.8M | ||
| Q1 24 | $6.6M | $-6.8M |
| Q4 25 | 7.8% | 13.8% | ||
| Q3 25 | -6.2% | 28.8% | ||
| Q2 25 | 15.5% | 0.1% | ||
| Q1 25 | -2.8% | -14.5% | ||
| Q4 24 | 8.0% | 11.2% | ||
| Q3 24 | -14.1% | -15.9% | ||
| Q2 24 | 8.4% | 3.4% | ||
| Q1 24 | 24.8% | -13.3% |
| Q4 25 | 0.4% | 2.4% | ||
| Q3 25 | 1.5% | 3.9% | ||
| Q2 25 | 1.5% | 12.9% | ||
| Q1 25 | 0.2% | 27.0% | ||
| Q4 24 | 7.2% | 18.3% | ||
| Q3 24 | 5.6% | 33.5% | ||
| Q2 24 | 3.8% | 31.8% | ||
| Q1 24 | 0.4% | 27.3% |
| Q4 25 | 7.16× | 0.65× | ||
| Q3 25 | -1.31× | 4.35× | ||
| Q2 25 | 4.85× | — | ||
| Q1 25 | -0.54× | — | ||
| Q4 24 | 11.71× | 1.12× | ||
| Q3 24 | -2.10× | — | ||
| Q2 24 | 6.58× | — | ||
| Q1 24 | 4.79× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MAMA
Segment breakdown not available.
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
